Desulfohalotomaculum Details: NCBI 2282743, gram-negative or unknown [genus]
| Desulfohalotomaculum| Desulfohalotomaculum Watanabe et al. 2018
Gastrointestinal Health: Bifidobacterium breve is known for its ability to colonize the human colon and help maintain a balanced and healthy gut microbiota. A balanced gut microbiota is associated with digestive health and may contribute to the prevention of gastrointestinal issues.
Immune System Support: Some studies suggest that certain strains of Bifidobacterium, including B. breve, may have immunomodulatory effects, potentially supporting the immune system. However, more research is needed to fully understand the mechanisms and implications.
Allergy Prevention: There is some evidence to suggest that Bifidobacterium breve may play a role in preventing allergies, particularly in infants. It is believed to contribute to the development of a balanced immune system, reducing the risk of allergic reactions.
Inflammatory Bowel Diseases (IBD): Some studies have explored the potential use of Bifidobacterium breve in managing inflammatory bowel diseases, such as ulcerative colitis and Crohn's disease. The results are mixed, and more research is needed to determine the specific strains and conditions under which these probiotics may be beneficial.
Infant Health: Bifidobacterium breve is commonly found in the gut microbiota of breastfed infants. It is believed to contribute to the development of a healthy gut microbiota in early life, which may have long-term health implications.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
- Immune Epitope Database
- The NCBI taxonomy database
- UniProt
- Immune Epitope Taxonomy Database (IEDB)
- AI Engines For more Details: Perplexity Kagi Labs You
 Statistics
|
NCBI | Data Punk | End Products Produced |
Lab Reporting
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Desired Levels Suggestions for Desulfohalotomaculum
- Frequency - how often do samples show this bacteria
- UD - An alternative statistical algorithm (which factors in the frequency)
- Kaltoft-Moldrup Heuristic Using uploaded data
- Lab Low and High are calculated using the formula that most labs use: Mean - 2 Standard Deviation to Mean + 2 Standard Deviation
| Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Labs | 0.13 | 20 | 108 | 0 | 153 | 66 | 70 | 44.1 | 20 | 108 | 20 %ile | 60 %ile | ||
| biomesight | 9.3 | 0 | 0 | 10 | 760 | 0 | 194 | 37.7 | 20 | 79.5 | 0 | 40 | 0 %ile | 100 %ile |
| thryve | 72.83 | 0 | 66 | 22 | 121 | 0 | 402 | 86.4 | 51 | 161.2 | 5 | 145 | 12.2 %ile | 90.4 %ile |
External Reference Ranges for Desulfohalotomaculum
| Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
|---|
Statistic by Lab Source for Desulfohalotomaculum
| Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
|---|---|---|---|---|---|
| BiomeSight | 10.455 % | 0.003 % | 0.007 % | 310.0 | 2965 |
| BiomeSightRdp | 3.226 % | 0.002 % | % | 1.0 | 31 |
| bugspeak | 100 % | 0.007 % | % | 1.0 | 1 |
| custom | 1.639 % | 0.011 % | % | 1.0 | 61 |
| Thryve | 69.828 % | 0.008 % | 0.015 % | 972.0 | 1392 |
|
|
To see medical conditions associated you may be logged in
And display level must be raised above public.
I would like to know what can change the quality that I have
- If I want to know that a substance also changes, then I just click on it
- If I want to know which study this information comes from, then I just clink in increases or decreases
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.